drugset / Trial / NCT02428205

Combined Effects of Early Behavioral Intervention and Propranolol on ASD

NCT02428205

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to explore the effects of propranolol in combination with early intensive behavioral intervention on social interaction, and secondarily on language, anxiety, adaptive behaviors, and global function in children with autism in a double-blinded, placebo-controlled pilot trial.

Timeline

Start
2015-04
Primary completion
2022-11-01
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 2 mg Oral
Subject Propranolol Small molecule 3 mg Oral
Subject Propranolol Small molecule 4 mg Oral

Indications